Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VisionMed is a private healthcare AI company developing software for automated documentation, analytics, and intelligence around medical procedures. Its core product, EMMA (Expert Multimodal Medical Agent), analyzes procedural video and related data to generate structured clinical notes, event timelines, and reviewable procedural information for clinicians. The company positions its technology as a procedural intelligence layer that integrates with existing medical-device video feeds and clinical workflows rather than as a therapeutics developer. VisionMed appears to be commercially active, with public statements describing a commercial launch phase in 2025 and subsequent partnerships in surgical education. The business is best categorized as a digital health and medical technology company serving providers across surgical and interventional settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VisionMed.